Statins and risk of treated incident diabetes in a primary care population
about
Risk of new-onset diabetes associated with statin useStatins for primary cardiovascular prevention in the elderlyRole of colesevelam in combination lipid-lowering therapyLipid, blood pressure and kidney update 2013.Safety and efficacy of colesevelam HCl in the treatment of elderly patientsLowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus.Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes.Do statins increase and Mediterranean diet decrease the risk of breast cancer?A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia.Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?The vascular endothelium in diabetes--a therapeutic target?Incident diabetes and statins: the blemish of an undisputed heavy weight champion?Risk of incident diabetes among patients treated with statins: population based study.Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.Performance of the high-dimensional propensity score in adjusting for unmeasured confounders.Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.Statin treatment, new-onset diabetes, and other adverse effects: a systematic review.An update on the benefits and risks of rosuvastatin therapy.Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications.Statins and their increased risk of inducing diabetes.Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism.Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.Diabetes Secondary to Treatment with Statins.Toxicity of Atorvastatin on Pancreas Mitochondria: A Justification for Increased Risk of Diabetes Mellitus.Use of Statins and the Risk of Incident Diabetes: A Retrospective Cohort Study.Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.Protective effects of coenzyme Q10 and L-carnitine against statin-induced pancreatic mitochondrial toxicity in rats.Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction.2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document.Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.Variable effects of statins on glucose homeostasis parameters and their diabetogenic role. Reply to Kostapanos MS, Agouridis AP and Elisaf MS [letter].Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million Patients
P2860
Q26771800-F4CB747A-0CFB-4973-B580-43259B477990Q26783401-4114DDF3-C306-47EF-AB11-EAE8FDF04E9BQ27016027-8CAFF1E8-A7F1-4D52-8C41-0F0861DC302BQ33574532-5E1BDBA0-FFB9-46AA-8A4A-77E239AF5181Q33663484-1D4DF170-FFCD-4D26-874E-F259A9075569Q33890208-637BFFB6-BC5E-431F-97B8-68AEDE3A68A6Q33900403-5CB0EB2C-4E56-4A36-A49A-5CAA52367478Q34128364-F2CD8BFE-57B9-41B1-B719-EEE740970029Q34500694-8A0D7C47-BF75-489B-83D1-0A4C816BDF8FQ35669490-CEC4EEA3-537C-424F-8EA1-068F4ED1DD64Q35927675-04E4E09C-640F-4A7F-AA15-EB23FB763E68Q36411656-3E8DC977-A550-4B8E-BC4A-19F4ABFDC453Q36673550-856557A8-8E3B-480F-84AC-0381A9CCD87DQ36729910-F32AB88F-392F-4C07-9B70-764DB59CB169Q36871618-71B29915-26EB-489F-B036-FCE622FD184FQ37359219-FAD119CD-F95A-4E84-8026-1229A0779217Q37416238-3A62094A-67C4-4CE3-BBD6-50F1A456A94FQ37433115-7B6B3DFC-14F4-4C20-A56D-2F8790A648ABQ38181977-481C41A7-5822-4735-9B9C-1044718C20C1Q38200826-451EDFE4-6571-482C-833A-1D2846C34326Q38208727-05041BA4-49B8-4134-86AA-B56493F9B972Q38222135-FC56D49C-BA8E-496C-8A53-35C5F432B7BFQ38599323-AC380FBC-29A7-4F53-8882-8550EC3B0C72Q38600327-0B0EA310-09BC-47FA-8892-378D7E5CBD06Q38699252-E5DC92FE-12F4-4905-B430-8BDD6BFE7297Q38757502-7C1BE4CE-5700-4A51-ADCB-3989834C107EQ39117136-7B41ACE7-CFD9-4AA8-B05D-88760D768251Q39461691-F30642E2-A26E-4BBB-B6B5-2D8D7D2D6D35Q39703523-9073973D-7A6A-464C-94ED-56A88CD3A2DBQ41093207-D70E0456-B29C-489F-B291-E9D86804066CQ46035508-B4BAA116-DF1D-4631-B1C3-2B4F916403A2Q47146839-ED1A53F2-D12F-4AA4-8412-E057DAFC6A4CQ48123127-9A4B6E3F-CE22-4A3D-9D8B-A3519CE05A6DQ51306758-646C9D87-0437-43AF-B088-A4BB7107267CQ53836035-BC3847A0-0E1D-4D9C-8565-827D12AF24EDQ58698213-A0B01A5E-C170-4FB0-9291-C3B54F9D3299
P2860
Statins and risk of treated incident diabetes in a primary care population
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Statins and risk of treated incident diabetes in a primary care population
@ast
Statins and risk of treated incident diabetes in a primary care population
@en
type
label
Statins and risk of treated incident diabetes in a primary care population
@ast
Statins and risk of treated incident diabetes in a primary care population
@en
prefLabel
Statins and risk of treated incident diabetes in a primary care population
@ast
Statins and risk of treated incident diabetes in a primary care population
@en
P2093
P2860
P1476
Statins and risk of treated incident diabetes in a primary care population
@en
P2093
David Williams
Kathleen Bennett
Nur Lisa Zaharan
P2860
P304
P356
10.1111/J.1365-2125.2012.04403.X
P407
P577
2013-04-01T00:00:00Z